There is a strong political commitment to nurturing Belgian leadership in biopharmaceuticals and stimulating this key asset of the Belgian economy. Some of the recent measures include:
• the fastest approval for phase 1 clinical trials in Europe (2 weeks)
• newly established Federal Agency for Medicines and Health
• full support of public authorities for the development of biotech clusters, bringing together universities, companies and research centers -- BioWin (Health Cluster of Wallonia), FlandersBio (Biotech Cluster of Flanders) and Bio&Pharma in Brussels